Mifepristone for preinduction cervical ripening beyond 41 weeks' gestation: A randomized controlled trial

Obstetrics and Gynecology

Volumn 96, Issue 4, 2000, Pages 543-548

  Wing, Deborah A ^a   Fassett, Michael J ^a   Mishell Jr, Daniel R ^a  

^a Division of Maternal Fetal Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MIFEPRISTONE; MISOPROSTOL; OXYTOCIN; PLACEBO;

ADULT; ARTICLE; CHORIOAMNIONITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DYSTOCIA; FEMALE; FETUS ELECTROCARDIOGRAPHY; FETUS HEART RATE; FETUS OUTCOME; HUMAN; LABOR INDUCTION; MAJOR CLINICAL STUDY; OUTCOMES RESEARCH; PREGNANCY TERMINATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; UTERINE CERVIX RIPENING; UTERUS CONTRACTION;

ADULT; CERVICAL RIPENING; CESAREAN SECTION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LABOR, INDUCED; MIFEPRISTONE; MISOPROSTOL; OXYTOCICS; OXYTOCIN; PREGNANCY; PREGNANCY, PROLONGED;

EID: 0033835784     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(00)00947-9     Document Type: Article

References (23)

1. LaGrew D.C., Freeman R.K. Management of postdate pregnancy. Am J Obstet Gynecol. 154:1986;8-13.
2. Naeye R.L. Causes of perinatal mortality excess in prolonged gestations. Am J Epidemiol. 108:1978;429-433.
3. Usher R.H., Boyd M.E., McLean F.H., Kramer M.S. Assessment of fetal risk in postdate pregnancies. Am J Obstet Gynecol. 158:1988;259-264.
4. Racker D., Burgress G.H., Manly G. The management of postmaturity. Lancet. 2:1953;953-956.
5. Hannah M.E., Hannah W.J., Hellman J., Hewson S., Milner R., Willan A. Induction of labor as compared with serial antenatal monitoring in post-term pregnancy. A randomized controlled trial. The Canadian Multicenter Post-term Pregnancy Trial group. N Engl J Med. 326:1992;1587-1592.
6. Swahn M.L., Bygdeman M. The effect of the antiprogestin RU 486 on uterine contractility and sensitivity to prostaglandin and oxytocin. Br J Obstet Gynaecol. 95:1988;126-134.
7. Johnson N., Bryce F.C. Could antiprogesterones be used as alternative cervical ripening agents? Am J Obstet Gynecol. 162:1990;688-690.
8. Norman J.E., Thong K.J., Baird D.T. Uterine contractility and induction of abortion in early pregnancy by misoprostol and mifepristone. Lancet. 338:1991;1233-1236.
9. Thong K.J., Baird D.T. Induction of abortion with mifepristone and misoprostol in early pregnancy. Br J Obstet Gynaecol. 99:1992;1004-1007.
10. Peyron R., Aubeny E., Targosz V., Silvestre L., Renault M., Elkik F., et al. Early termination of pregnancy with mifepristone (RU 486) and the orally active prostaglandin misoprostol. N Engl J Med. 328:1993;1509-1513.
11. El-Refaey H., Rajasekar D., Abdalla M., Calder L., Templeton A. Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol. N Engl J Med. 332:1995;983-987.
12. Frydman R., Lelaidier C., Baton-Saint-Mleux C., Fernandez H., Vial M., Bourget P. Labour induction in women at term with mifepristone (RU 486) A double-blind, randomized, placebo-controlled study . Obstet Gynecol. 80:1992;972-975.
13. Lelaidier C., Baton C., Benifla J.L., Fernandez H., Bourget P., Frydman R. Mifepristone for labour induction after previous caesarean section. Br J Obstet Gynaecol. 101:1994;501-503.
14. Giacalone P.L., Targosz V., Laffargue F., Boog G., Faure J.M. Cervical ripening with mifepristone before labor induction A randomized study . Obstet Gynecol. 92:1998;487-492.
15. Elliott C.L., Brennand J.E., Calder A.A. The effects of mifepristone on cervical ripening and labor induction in primigravidae. Obstet Gynecol. 92:1998;804-809.
16. Kubli F.W., Hon E.H., Khazin A.F., Takemura H. Observations on heart rate and pH in the human fetus during labor. Am J Obstet Gynecol. 104:1969;1190-1206.
17. Stookey R.A., Sokol R.J., Rosen M.G. Abnormal contraction patterns in patients monitored during labor. Obstet Gynecol. 42:1973;359-367.
18. Li L., Gao W., Chen S. Labour induction in women at term with mifepristone and misoprostol. Chung Hua Fu Chan Ko Tsa Chih. 31:1996;681-684.
19. Rodger M.W., Baird D.T. Pretreatment with mifepristone (RU 486) reduces the interval between prostaglandin administration and expulsion in second trimester abortion. Br J Obstet Gynaecol. 97:1990;41-45.
20. Frydman R., Fernandez H., Pons J.C., Ulmann A. Mifepristone (RU486) and therapeutic late pregnancy termination A double-blind study of two different doses . Hum Reprod. 3:1988;803-806.
21. Hill N.C., Selinger M., Ferguson J., Lopez Bernal A., MacKenzie I.Z. The physiological and clinical effects of progesterone inhibition with mifepristone (RU 486) in the second trimester. Br J Obstet Gynaecol. 97:1990;487-492.
22. Hill N.C., Selinger M., Ferguson J., MacKenzie I.Z. The placental transfer of mifepristone (RU 486) during the second trimester and its influence upon maternal and fetal steroid concentrations. Br J Obstet Gynaecol. 97:1990;406-411.
23. Haluska G.J., Stanczyk F.Z., Cook M.J., Novy M.J. Temporal changes in uterine activity and prostaglandin response to RU486 in rhesus macaques in late gestation. Am J Obstet Gynecol. 157:1987;1487-1495.